title: Dialysis facility profit status and compliance with a black box warning.
authors.forename: Julie H
authors.initials: JH
authors.lastname: Ishida
authors.forename: Charles E
authors.initials: CE
authors.lastname: McCulloch
authors.forename: R Adams
authors.initials: RA
authors.lastname: Dudley
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Grimes
authors.forename: Kirsten L
authors.initials: KL
authors.lastname: Johansen
mesh_terms: D000368:Aged; D000554:Ambulatory Care Facilities / Q000191:economics / Q000592:standards; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000191:economics* / Q000209:etiology; D015331:Cohort Studies; D004921:Erythropoietin / Q000008:administration & dosage* / Q000191:economics*; D005260:Female; D019983:Guideline Adherence; D005102:Health Expenditures / Q000639:trends*; D006400:Hematocrit; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000592:standards; D017149:Private Sector / Q000191:economics / Q000592:standards; D017150:Public Sector / Q000191:economics / Q000592:standards; D006435:Renal Dialysis / Q000009:adverse effects / Q000191:economics*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004921:Erythropoietin